Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

Mario Messina, Chiara Stagnaro, Rossella Angotti et al.|Clinical Rheumatology|2018

Cited by 82